**Trustees' Annual Report for the period** 

**19** 


Period start date Period end date 01 08 2022 31 07 2023 **From To** 

## Section A                        Reference and administration details 

**Charity name Other names charity is known by Registered charity number (if any)** 1186396 **Charity's principal address** 2 Three Valleys Way 

Sickle Cell Awareness UK 

Bushey **Postcode WD23 2FF** 

## **Names of the charity trustees who manage the charity** 

||1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year **|**Name of person (or body) entitled**<br>**to appoint trustee (ifany)**|
|---|---|---|---|---|---|
|||Fajuyitan Opebiyi|Chairman|01/08/2022 – 31/07/2023||
|||Olajumoke<br>Oladiran|Treasurer|01/08/2022 – 31/07/2023||
|||Joseph A<br>Fawehinmi||01/08/2022 – 31/07/2023||
|||Bankole A<br>Olagbaiye||01/08/2022 – 31/07/2023||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||**Names of the trustees for the charity, if any, (for example, any custodian trustees)**||||
|||**Name**||**Dates acted if not for whole year**||
|||||||



**TAR** 

March **2012** 

1 



**Names and addresses of advisers (Optional information) Type of adviser Name Address Name of chief executive or names of senior staff members (Optional information)** 

## **Section B              Structure, governance and management** 

## **Description of the charity’s trusts** 

Charitable Incorporated Organisation: Model Type of governing document constitution for a CIO whose only voting members (eg. trust deed, constitution) Trust How the charity is constituted (eg. trust, association, company) Appointed by Trust board Trustee selection methods (eg. appointed by, elected by) 

## **Additional governance issues (Optional information)** 

You **may choose** to include additional information, where relevant, about: 

- policies and procedures adopted for the induction and training of trustees; 

- the charity’s organisational structure and any wider network with which the charity works; 

- relationship with any related parties; 

- trustees’ consideration of major risks and the system and procedures to manage them. 

## **Section C                    Objectives and activities** 

**TAR** 

March **2012** 

2 



To preserve and protect the good health of those with sickle cell for the public benefit by:1. Providing education and awareness of sickle cell through enlightening events; 2. To make grants in the trustees absolute discretion to support sickle cell **Summary of the objects of the** charities; **charity set out in its** 3. To fund research and publish all useful results arising from any **governing document** research supported; and 4. To engage with corporate organisations to include sickle cell health sponsorship on their charity objectives which the trustees deem appropriate in furthering the object of the organisation. Held Sickle Cell Awareness Day workshops with a major insurance Company in the City of London. **Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** 

## **Additional details of objectives and activities (Optional information)** 

**TAR** 

March **2012** 

3 



You **may choose** to include further statements, where relevant, about: 

- policy on grantmaking; 

- policy programme related investment; 

- contribution made by volunteers. 

## Section D                      Achievements and performance 

**TAR** 

March **2012** 

4 



## Section D                      Achievements and erformance p 

Created Awareness events with corporate companies in the City of **Summary of the main** London **achievements of the charity during the year** 

**TAR** 

March **2012** 

5 



## **Section E                    Financial review** 

## **Brief statement of the** 

**charity’s policy on reserves** 

**Details of any funds materially in deficit** 

## **Further financial review details (Optional information)** 

You **may choose** to include additional information, where relevant about: 

- the charity’s principal sources of funds (including any fundraising); 

- how expenditure has supported the key objectives of the charity; 

- investment policy and objectives including any ethical investment policy adopted. 

## **Section F                     Other optional information** 

## **Section G                    Declaration** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

**Signature(s)** F.O.Opebiyi **Full name(s)** Fajuyitan Olaolu Opebiyi **Position (eg Secretary, Chair,** Chair **etc) Date** 01/08/2024 

**TAR** 

March **2012** 

6 




**Sickle Cell Awareness UK No (if any) Receipts and payments accounts CC16a For the period** Period start date Period end date **To from** 8/1/2022 7/31/2023 

## **Section A Receipts and payments** 

|**Section A Receipts and payments**|||||
|---|---|---|---|---|
|**A1 Receipts**<br>None<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total receipts_                            -**<br>**A3 Payments**<br>None<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                                -**<br>**-**<br>**-**<br>**_Sub total_                                -**<br>**_Total payments_                            -**<br>**_Net of receipts/(payments)_                            -**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**-**<br>**_Cash funds this year end_                            -**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases, (see table)**|**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Last year**<br>**to the nearest £**|
|||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||||
|||**-**<br>**-**<br>**-**|**-**||
||||**-**|**-**|
||||**-**|**-**|
||||||
|||**-**|**-**|**-**|
||||||
|||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||||
|||**-**<br>**-**<br>**-**|**-**||
||||**-**||
||||**-**|**-**|
||||||
|||**-**|**-**|**-**|
||||||
||**-**|**-**<br>**-**<br>**-**<br>**-**|**-**|**-**|
||**-**||**-**|**-**|
||**-**||**-**|**-**|
||**-**||**-**|**-**|





|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|
|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>Signed by one or two trustees on<br>behalf of all the trustees|**Details**<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>Signature<br>F. O. Opebiyi<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>OK<br>OK<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Fajuyitan Olaolu Opebiyi<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||F. O. Opebiyi|Fajuyitan Olaolu Opebiyi|7/31/2021|
|||||



